News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dr. James J. Collins, A Pioneer In Synthetic Biology, Joins The Scientific Advisory Board Of Agilis Biotherapeutics


3/5/2014 9:28:47 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Agilis Biotherapeutics, LLC, a synthetic biology-based company focused on developing DNA-based therapeutics for rare genetic diseases, announced today Professor James J. Collins, Ph.D., a pioneer in the field of synthetic biology, has joined its Scientific Advisory Board. Dr. Collins' scientific achievements and accomplishments have been recognized by numerous organizations for his groundbreaking work and fundamental discoveries in the field of synthetic biology.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES